[Intermediate dose of Ara-C (IDAra-C) for the treatment of refractory and relapsed lymphoid malignancies].
Taniguchi
S
S
Shibuya
T
T
Morioka
E
E
Ohhara
N
N
Ohtsuka
T
T
Hirota
Y
Y
Yamano
Y
Y
Miki
K
K
Asano
Y
Y
Niho
Y
Y
D000293:Adolescent; D000328:Adult; D000368:Aged; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*
D003561:Cytarabine